DE69406763D1 - Pyridazinon Derivate, Herstellungsverfahren und Verwendung - Google Patents

Pyridazinon Derivate, Herstellungsverfahren und Verwendung

Info

Publication number
DE69406763D1
DE69406763D1 DE69406763T DE69406763T DE69406763D1 DE 69406763 D1 DE69406763 D1 DE 69406763D1 DE 69406763 T DE69406763 T DE 69406763T DE 69406763 T DE69406763 T DE 69406763T DE 69406763 D1 DE69406763 D1 DE 69406763D1
Authority
DE
Germany
Prior art keywords
group
carbon atoms
integer
pyridazinone derivatives
atom
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69406763T
Other languages
English (en)
Other versions
DE69406763T2 (de
Inventor
Takashi Kagawa
Takuya Motokawa
Masanori Yoshida
Yoshitami Oshita
Kazuo Kanai
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nihon Nohyaku Co Ltd
Original Assignee
Nihon Nohyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nihon Nohyaku Co Ltd filed Critical Nihon Nohyaku Co Ltd
Application granted granted Critical
Publication of DE69406763D1 publication Critical patent/DE69406763D1/de
Publication of DE69406763T2 publication Critical patent/DE69406763T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/14Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/22Nitrogen and oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE69406763T 1993-12-16 1994-12-15 Pyridazinon Derivate, Herstellungsverfahren und Verwendung Expired - Fee Related DE69406763T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP34340593 1993-12-16

Publications (2)

Publication Number Publication Date
DE69406763D1 true DE69406763D1 (de) 1997-12-18
DE69406763T2 DE69406763T2 (de) 1998-03-12

Family

ID=18361263

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69406763T Expired - Fee Related DE69406763T2 (de) 1993-12-16 1994-12-15 Pyridazinon Derivate, Herstellungsverfahren und Verwendung

Country Status (13)

Country Link
US (1) US5604226A (de)
EP (1) EP0658555B1 (de)
KR (1) KR950017967A (de)
CN (1) CN1109878A (de)
AT (1) ATE160144T1 (de)
AU (1) AU675889B2 (de)
CA (1) CA2138224A1 (de)
DE (1) DE69406763T2 (de)
DK (1) DK0658555T3 (de)
ES (1) ES2112470T3 (de)
GR (1) GR3026006T3 (de)
NZ (1) NZ270130A (de)
TW (1) TW326041B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9514160D0 (en) * 1994-07-25 1995-09-13 Zeneca Ltd Aromatic compounds
CN1163230C (zh) * 1998-12-07 2004-08-25 日产化学工业株式会社 勃起功能障碍治疗剂
KR100811865B1 (ko) * 2006-12-08 2008-03-10 주식회사 레고켐 바이오사이언스 인자 Ⅶa 억제 활성을 갖는 피리미디논 또는 피리다지논유도체

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4978665A (en) * 1987-01-20 1990-12-18 Nissan Chemical Industries Ltd. 3(2H)pyridazinone, and antagonistic agent against SRS-A containing it
JPH02256668A (ja) * 1988-12-20 1990-10-17 Nissan Chem Ind Ltd ピリダジノン誘導体
JPH07107055B1 (de) * 1990-04-25 1995-11-15
JPH05112454A (ja) * 1991-10-18 1993-05-07 Nissan Chem Ind Ltd 抗血小板剤

Also Published As

Publication number Publication date
AU675889B2 (en) 1997-02-20
AU8041394A (en) 1995-06-22
NZ270130A (en) 1995-12-21
CN1109878A (zh) 1995-10-11
DK0658555T3 (da) 1997-12-22
GR3026006T3 (en) 1998-04-30
KR950017967A (ko) 1995-07-22
DE69406763T2 (de) 1998-03-12
CA2138224A1 (en) 1995-06-17
EP0658555A1 (de) 1995-06-21
ATE160144T1 (de) 1997-11-15
TW326041B (en) 1998-02-01
US5604226A (en) 1997-02-18
ES2112470T3 (es) 1998-04-01
EP0658555B1 (de) 1997-11-12

Similar Documents

Publication Publication Date Title
EG20396A (en) Process for preparing of 5-aryundole derivatives
GB2262093B (en) Piperazine derivatives
ATE71090T1 (de) Heterocyclische verbindungen und deren herstellung und verwendung.
IL98829A0 (en) Novel 3-arylindole and 3-arylindazole derivatives
TW429255B (en) Pyrazine compounds having treatment of central nervous system diseases and disorders
EP0259835A3 (en) Pyridazinone derivatives
GB9026114D0 (en) New compounds
CS743389A3 (en) Amino(methyl)phenyl derivatives, process for their preparation and use
ES2065994T3 (es) Beta-dicetonas substituidas.
DE69119282D1 (de) Aminobenzolverbindungen, Herstellung und Verwendung
DE69406763D1 (de) Pyridazinon Derivate, Herstellungsverfahren und Verwendung
WO1999021848A3 (en) Novel 1-(n'-(arylalkylaminoalkyl))aminoisoindoles; a new class of dopamine receptor subtype specific ligands
EP0407032A3 (en) Aromatic and heteroaromatic amines for treating depressions, cerebral insufficiency disorders or dementia
ATE28639T1 (de) Derivate von 4-(3-alkynyloxy-2-hydroxy-propyl)piperazin-1-yl-n-phenylacetamid, ihre herstellung und ihre therapeutische verwendung.
IT1204459B (it) Derivati eterociclici
ES502073A0 (es) Metodo de producir lactamas antihipertensoras
PT99250A (pt) Processo para a preparacao de derivados de piperazina
ATE19881T1 (de) Tropyl- und pseudotropylalkylbenzoate und ihre verwendung in der behandlung von migraene.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee